
Lymphoma News


Ask the Doctor: Are there any oral therapies that are currently under investigation for frontline MCL?

Glass Half Full: A Story of Hope
At 24 years old, Nina Luker’s life was turned upside down when she learned she had stage IV diffuse large B-cell lymphoma (DLBCL) – just three days before New York City went on lockdown due to the 2020 COVID-19 Pandemic.…

Shining a Light on Lymphoma During Blood Cancer Awareness Month
Shinning a Light on Lymphoma During Blood Cancer Awareness Month Due in large part to the Lymphoma Research Foundation’s (LRF) Advocacy Program, the month of September was designated Blood Cancer Awareness Month (BCAM) by the U.S. Congress in 2010. Blood…

U.S. Food and Drug Administration Approves Belumosudil (REZUROCK) for Chronic Graft-Versus-Host Disease

Ask the Doctor: Is there any increased risk of FL transforming during watch and wait?

An Enduring Legacy of Hope and Impact

U.S. Food and Drug Administration Approves Loncastuximab Tesirine-lpyl for Large B-cell Lymphoma

Ask the Doctor: How can we determine the efficacy of the COVID-19 vaccine and how we may respond?
As the rollout of the new COVID-19 vaccines continues, there is constant new data related to the vaccines and their effects on individuals. While most of this data is preliminary, information related to the efficacy and effect of the vaccine…

Ask the Doctor: How do physicians determine when follicular lymphoma has transformed to DLBCL? What kind of tests or symptoms help doctors monitor this?
Transformed lymphoma occurs when an indolent lymphoma turns into a more aggressive one. A transformation occurs when genetic changes in the indolent lymphoma cells cause them to begin growing faster and behaving more aggressively. Lymphoma Research Foundation Grantee Raphael Eric…